Jdp Drug Patent Portfolio
Jdp owns 1 orange book drug protected by 5 US patents Given below is the list of Jdp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof | 28 Feb, 2030 | Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof | 11 Feb, 2030 | Active |
Latest Legal Activities on Jdp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Jdp.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 May, 2024 | US8314083 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Feb, 2024 | US8263581 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Feb, 2023 | US9119771 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US8513259 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US9119771 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 23 Apr, 2021 | US8314083 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Jan, 2021 | US8513259 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 15 Apr, 2020 | US8314083 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Apr, 2020 | US8263581 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 15 Apr, 2020 | US8263581 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 11 Nov, 2019 | US8263581 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Oct, 2019 | US9119771 |
|
Email Notification
Critical
| 02 Oct, 2019 | US9119771 |
|
Correspondence Address Change
Critical
| 01 Oct, 2019 | US9119771 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Jul, 2019 | US8513259 |
Jdp's Family Patents
Jdp drugs have patent protection in a total of 5 countries. It has a significant patent presence in the US with 73.3% of its patents being US patents. Click
below to unlock the full patent family tree.
Jdp Drug List
Given below is the complete list of Jdp's drugs and the patents protecting them.
1. Quzyttir
Quzyttir is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8263581 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(5 years from now)
| Active |
| US8314083 | Non-sedating antihistamine injection formulations and methods of use thereof |
28 Feb, 2030
(5 years from now)
| Active |
| US8513259 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(5 years from now)
| Active |
| US9119771 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(5 years from now)
| Active |
| US9180090 | Non-sedating antihistamine injection formulations and methods of use thereof |
11 Feb, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Quzyttir's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List